Su L - Search Results

1

A dityrosyl-diiron radical cofactor center is essential for human ribonucleotide reductases.

Zhou B, Shao J, Su L, Yuan YC, Qi C, Shih J, Xi B, Chu B, Yen Y. Zhou B, et al. Among authors: su l. Mol Cancer Ther. 2005 Dec;4(12):1830-6. doi: 10.1158/1535-7163.MCT-05-0273. Mol Cancer Ther. 2005. PMID: 16373698

2

Flavone and isoflavone phytoestrogens are agonists of estrogen-related receptors.

Suetsugi M, Su L, Karlsberg K, Yuan YC, Chen S. Suetsugi M, et al. Among authors: su l. Mol Cancer Res. 2003 Nov;1(13):981-91. Mol Cancer Res. 2003. PMID: 14638870

3

Determination of the potency and subunit-selectivity of ribonucleotide reductase inhibitors with a recombinant-holoenzyme-based in vitro assay.

Shao J, Zhou B, Zhu L, Bilio AJ, Su L, Yuan YC, Ren S, Lien EJ, Shih J, Yen Y. Shao J, et al. Among authors: su l. Biochem Pharmacol. 2005 Feb 15;69(4):627-34. doi: 10.1016/j.bcp.2004.11.016. Epub 2005 Jan 8. Biochem Pharmacol. 2005. PMID: 15670581

4

2.6 A X-ray crystal structure of human p53R2, a p53-inducible ribonucleotide reductase.

Smith P, Zhou B, Ho N, Yuan YC, Su L, Tsai SC, Yen Y. Smith P, et al. Among authors: su l. Biochemistry. 2009 Nov 24;48(46):11134-41. doi: 10.1021/bi9001425. Biochemistry. 2009. PMID: 19728742 Free PMC article.

5

Structural basis on the dityrosyl-diiron radical cluster and the functional differences of human ribonucleotide reductase small subunits hp53R2 and hRRM2.

Zhou B, Su L, Yuan YC, Un F, Wang N, Patel M, Xi B, Hu S, Yen Y. Zhou B, et al. Among authors: su l. Mol Cancer Ther. 2010 Jun;9(6):1669-79. doi: 10.1158/1535-7163.MCT-10-0023. Epub 2010 May 18. Mol Cancer Ther. 2010. PMID: 20484015 Free PMC article.

6

A small-molecule blocking ribonucleotide reductase holoenzyme formation inhibits cancer cell growth and overcomes drug resistance.

Zhou B, Su L, Hu S, Hu W, Yip ML, Wu J, Gaur S, Smith DL, Yuan YC, Synold TW, Horne D, Yen Y. Zhou B, et al. Among authors: su l. Cancer Res. 2013 Nov 1;73(21):6484-93. doi: 10.1158/0008-5472.CAN-13-1094. Epub 2013 Sep 26. Cancer Res. 2013. PMID: 24072748 Free PMC article.

7

A germline missense mutation in COQ6 is associated with susceptibility to familial schwannomatosis.

Zhang K, Lin JW, Wang J, Wu X, Gao H, Hsieh YC, Hwu P, Liu YR, Su L, Chiou HY, Wang D, Yuan YC, Whang-Peng J, Chiu WT, Yen Y. Zhang K, et al. Among authors: su l. Genet Med. 2014 Oct;16(10):787-92. doi: 10.1038/gim.2014.39. Epub 2014 Apr 24. Genet Med. 2014. PMID: 24763291 Free PMC article.

8

The Novel Ribonucleotide Reductase Inhibitor COH29 Inhibits DNA Repair In Vitro.

Chen MC, Zhou B, Zhang K, Yuan YC, Un F, Hu S, Chou CM, Chen CH, Wu J, Wang Y, Liu X, Smith DL, Li H, Liu Z, Warden CD, Su L, Malkas LH, Chung YM, Hu MC, Yen Y. Chen MC, et al. Among authors: su l. Mol Pharmacol. 2015 Jun;87(6):996-1005. doi: 10.1124/mol.114.094987. Epub 2015 Mar 26. Mol Pharmacol. 2015. PMID: 25814515 Free PMC article.

9

Nelfinavir and nelfinavir analogs block site-2 protease cleavage to inhibit castration-resistant prostate cancer.

Guan M, Su L, Yuan YC, Li H, Chow WA. Guan M, et al. Among authors: su l. Sci Rep. 2015 Apr 16;5:9698. doi: 10.1038/srep09698. Sci Rep. 2015. PMID: 25880275 Free PMC article.

10

PYCR1 and PYCR2 Interact and Collaborate with RRM2B to Protect Cells from Overt Oxidative Stress.

Kuo ML, Lee MB, Tang M, den Besten W, Hu S, Sweredoski MJ, Hess S, Chou CM, Changou CA, Su M, Jia W, Su L, Yen Y. Kuo ML, et al. Among authors: su l, su m. Sci Rep. 2016 Jan 6;6:18846. doi: 10.1038/srep18846. Sci Rep. 2016. PMID: 26733354 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,578 results

Search Page

Filters